Search

4 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px"

12 Jan 2021: and officials got to events on time and that emergency vehicles could get through if needed. ... Transport for London knew the structure had some corrosion problems, and was actively monitoring its condition.

4 Jul 2024: company, has raised $31 million to continue developing its transformational products for characterising proteins and./p pThe post a ... 342px) 100vw, 342px" //a/div /div /blockquote /div pRead the full release a

4 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px"

4 Jul 2024: partnership/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p ... rel="noopener noreferrer"Lincoln/a and a href="http://www.reading.ac.uk/news-and-events/releases/PR762873.aspx" target="_blank" rel="noopener noreferrer

5 Jul 2024: 11 October 2023. Cambridge and Manchester launch new cross-UK innovation cluster to boost growth. ... There are also strong ties between the investment communities, through Cambridge Angels and Manchester Angels.

23 Oct 2020: Over the past decade, researchers have been investigating various methods of constructing nanopores in order to improve accuracy and reliability. ... Biological nanopores are cheap and easy to manufacture in large quantities of identical pores.

4 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px"

23 Feb 2023: Keith, formerly CEO of Cancer Research Technology, brings his extensive knowledge of developing and partnering early stage cancer programmes. ... Head of Biology, David Simmons (ex Cellzome, Celltech, Wyeth) and now strengthened by the appointment of VP

4 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px"

4 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px"

23 Oct 2020: Society for the encouragement of Arts, Manufactures and Commerce (RSA) and supported by Lloyds banking group. ... France – and continue the spiral of decline we are currently seeing in UK manufacturing.

4 Jul 2024: cam.ac.uk/news/lab-grown-mini-guts-could-help-in-development-of-new-and-more-personalised-treatments-for-crohns-disease/ Gianluca D'Uva Tue, 11 Jun 2024 16:20:20 ... 342px) 100vw, 342px" //a/div /div /blockquote /div pRead the full release a href="https:/

23 Oct 2020: Current drug treatments for AML suffer from poor efficacy and numerous unwanted side-effects. ... The Eurostars programme was established to assist small and medium enterprises (SMEs) in obtaining research and development funding.

4 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px"

23 Oct 2020: As well as supporting health and wellbeing in new cities, the new Centre will help deliver efficient energy use through its academic and entrepreneurial activities. ... The Vice-Chancellor was joined by Professor Sir Mark Welland, Head of the

23 Feb 2023: million Series A Funding with Medicxi and Johnson & Johnson Innovation to develop antibodies with anticoagulant properties. ... into the discovery of first-in-class drugs in oncology and other diseases.

22 Feb 2023: 10 July 2019. Academy award for founder and CEO of Cambridge spin-out. ... in applications ranging from power supplies for consumer electronics to LED drives, data centres and wireless chargers.

23 Oct 2020: Hockaday, CEO, Isis Innovation ltd and Tony Hickson, Managing Director Technology Transfer, Imperial Innovations plc. ... that UK universities take too much equity in spin-outs and more equity should be retained by founding entrepreneurs to incentivise

23 Oct 2020: 28 June 2018. Spin-out Morphogen-IX announces appointment of CEO and SAB members. ... The SAB comprises leading international experts in the field of PAH research, experimental medicine and clinical trials:.